Capsida announces multi-year agreement with Eli Lilly subsidiary

Thousand Oaks-based Capsida Therapeutics has entered into a multi-year agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, to develop transformative genetic medicines for serious diseases, Capisda announced Jan. 4. As per the agreement, Capsida will receive $55 million in the form of an upfront payment and a commitment to participate Read More →
Amgen buys Horizon Therapeutics for $27B
By Jorge Mercado Senior Staff Writer Thousand Oaks-based Amgen has announced its largest acquisition in company history, $27 billion for Horizon Therapeutics, positioning itself with a pipeline of treatments that could pay dividends over the coming decades. Amgen, one of the largest biotechnology companies in the world, beat out competition from Sanofi and Johnson and Read More →

Dantari raises $47M to target cancers and rare diseases

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Chumash join fight against food insecurity in SB
By Madeleine Benn Staff Writer Food insecurity is a great source of stress for nearly one in four members of the Santa Barbara County community. It is only exacerbated during the holiday season. On Dec. 6, the Santa Ynez Band of Chumash Indians donated both time and money to the Santa Barbara Foodbank’s Santa Maria Read More →

Briefcase: Healthwatch
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.